Questions remain over insurer participation

Category: ABS CLOs Regulation

Previous Story       Next Story

The European Commission recently published the Delegated Act on Solvency 2, which improves the capital treatment for certain ABS exposures, as of 1 January 2019. However, market participants suggest that STS securitisations deserve fairer capital treatment and, as a result, insurance firms remain unlikely to return to the securitisation market in great number.

Already registered?

Not yet registered? Join today to access SCI Content.